Thangamani, S., Younis, W., & Seleem, M. N. (2015). Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. Scientific Reports, 5, 11596. https://doi.org/10.1038/srep11596
Thangamani, S., Nepal, M., Chmielewski, J., & Seleem, M. N. (2015). Antibacterial activity and therapeutic efficacy of Fl-PRPRPL-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection. Drug Design, Development and Therapy, 9, 5749.https://doi.org/10.2147/DDDT.S94505
Thangamani, S., Mohammad, H., Abushahba, M. F., Sobreira, T. J., Hedrick, V. E., Paul, L. N., & Seleem, M. N. (2016). Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Scientific Reports, 6, 22571.10.1038/srep22571
Abushahba, M. F., Mohammad, H., & Seleem, M. N. (2016). Targeting multidrug-resistant staphylococci with an anti-rpoA peptide nucleic acid conjugated to the HIV-1 TAT cell penetrating peptide. Molecular Therapy-Nucleic Acids, 5, e339. https://doi.org/10.1038/mtna.2016.53
Keilberg, D., Zavros, Y., Shepherd, B., Salama, N. R., & Ottemann, K. M. (2016). Spatial and temporal shifts in bacterial biogeography and gland occupation during the development of a chronic infection. MBio, 7(5), e01705-16. https://doi.org/10.1128/mBio.01705-16
Gold Biotechnology (U.S. Registration No 3,257,927) and Goldbio (U.S. Registration No 3,257,926)
are registered trademarks of Gold Biotechnology, Inc.